Patent US5709676A successfully refreshed from Google Patents.
US5709676A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Synergistic treatment of stenosed blood vessels using shock waves and dissolving medication
Assignee: Boston Scientific Scimed Inc
•
Filing: 1995-11-27
•
Granted: 1998-01-20
•
Expires: 2015-11-27
Abstract
Abstract A method for removing a thrombus or plaque deposit from the wall of a blood vessel of a patient is enhanced by synergistic action of two individual procedures. A catheter is introduced into a blood vessel from which a thrombus or plaque deposit is to be removed. The first procedure is application of laser energy through an optical fiber in the catheter, in a wavelength range selected for preferred absorption by red blood cells in the blood vessel to generate a plasma-based ultrasonic shock wave in the vessel. The shock wave impacts on the thrombus or plaque deposit to open fissures therein. In the second procedure, a thrombus- or plaque-dissolving medication is injected into the blood stream in the vicinity of the plaque deposit through a lumen in the catheter, promptly after completion of the first procedure. The thrombus- or plaque-dissolving medication is used to penetrate into the fissures created in the thrombus or plaque deposit by the shock wave, to begin to break up or dissolve the thrombus or plaque of the deposit. Thereafter, the first and second procedures are repeated in the same sequence at least once, and preferably several times, to ultimately fragment the plaque deposit so that the fragments may be removed from the blood vessel through the channel in the catheter. The overall process, including several repetitions of the sequence of procedures, is carried out in about 10 minutes.
Inventors
- 👤 Eckhard Alt
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 13:40
CPC Classifications
A; A61; A61B; A61B18/00; A61B18/18; A61B18/20; A61B18/22; A61B18/26; A61B18/24; A61B18/245; A61B17/00; A61B17/22; A61B2017/22038; A61B2017/22082; A61B2017/22084
Claims Analysis
Total Claims: 31
Claim 1
Independent Claim
84 words
A method of treating clots in a blood vessel of a patient, which comprises the steps of alternately applying, first, laser energy in the vessel to induce a plasma-based shock wave through the blood to impact the clot to create fissures therein, and, then, a clot-dissolving medication in a local, non-systemic manner to the clot; repeating a sequence of shock wave and dissolving medication applications over a period of time sufficient to fragment the clot; and removing fragmented clot material from the patient's bloodstream.
Claim 2
Independent Claim
84 words
A method of treating clots in a blood vessel of a patient, which comprises the steps of alternately applying, first, laser energy in the vessel to induce a plasma-based shock wave through the blood to impact the clot to create fissures therein, and, then, a clot-dissolving medication in a local, non-systemic manner to the clot; repeating a sequence of shock wave and dissolving medication applications over a period of time sufficient to fragment the clot; and removing fragmented clot material from the patient's bloodstream.
Claim 3
Dependent Claim
35 words
The treatment method of claim 1, including applying each of the laser-induced shock wave and the clot-dissolving medication for an interval of about two minutes in a substantially uninterrupted sequence, and repeatedly performing the sequence.
Claim 4
Dependent Claim
56 words
The treatment method of claim 1, including applying each of the laser-induced shock wave and the clot-dissolving medication through a single catheter introduced into the blood vessel to a point sufficiently close to a site of the clot to enable said fragmentation of the clot to be achieved by combined and repeated action of said applications.
Claim 5
Dependent Claim
47 words
The treatment method of claim 1, including inducing the shock wave by creating a plasma through application of laser energy to the patient's blood adjacent the site of the clot at radiation wavelengths in a predetermined range which is susceptible to high absorption by red blood cells.
Claim 6
Dependent Claim
33 words
The treatment method of claim 4, including applying both said laser energy and said clot-dissolving medication through a single catheter introduced into the patient's vascular system from a point external to the body.
Claim 7
Dependent Claim
41 words
The treatment method of claim 1, including applying the clot-dissolving medication in each said sequence in a dosage less than capable to produce a systemic thrombolytic effect, to assure only local rather than systemic action thereof in the patient's vascular system.
Claim 8
Dependent Claim
12 words
The treatment method of claim 6, wherein the clot-dissolving medication is streptokinase.
Claim 9
Dependent Claim
12 words
The treatment method of claim 6, wherein the clot-dissolving medication is urokinase.
Claim 10
Dependent Claim
12 words
The treatment method of claim 6, wherein the clot-dissolving medication is rTPA.
Claim 11
Dependent Claim
17 words
The treatment method of claim 1, wherein said period of time is at least about ten minutes.
Claim 12
Independent Claim
150 words
A method of eliminating thrombus formations in a blood vessel of a patient, which comprises the steps of successively introducing laser energy in a predetermined wavelength range for preferred absorption by red blood cells of a thrombus in the blood vessel which is to be removed, to generate a plasma-based ultrasonic shock wave in the vessel for application to the thrombus to expose at least a portion of the interior of the thrombus, and promptly thereafter delivering a thrombus-dissolving medication into the blood stream in the region of said thrombus to be removed to penetrate to said exposed portion of the interior of the thrombus; and repeating said successive introduction of laser energy to re-generate said shock wave and said prompt delivery of thrombus-dissolving medication at least once again to fragment a portion of said thrombus, so that the fragmented portion of the thrombus may be removed from the vessel.
Claim 13
Independent Claim
150 words
A method of eliminating thrombus formations in a blood vessel of a patient, which comprises the steps of successively introducing laser energy in a predetermined wavelength range for preferred absorption by red blood cells of a thrombus in the blood vessel which is to be removed, to generate a plasma-based ultrasonic shock wave in the vessel for application to the thrombus to expose at least a portion of the interior of the thrombus, and promptly thereafter delivering a thrombus-dissolving medication into the blood stream in the region of said thrombus to be removed to penetrate to said exposed portion of the interior of the thrombus; and repeating said successive introduction of laser energy to re-generate said shock wave and said prompt delivery of thrombus-dissolving medication at least once again to fragment a portion of said thrombus, so that the fragmented portion of the thrombus may be removed from the vessel.
Claim 14
Dependent Claim
11 words
The method of claim 11, wherein the thrombus-dissolving medication is rTPA.
Claim 15
Dependent Claim
37 words
The method of claim 12, including delivering said thrombus-dissolving medication in a dosage of from about 1 to about 5 milligrams, whereby to restrict action thereof to locally in the vicinity of the thrombus rather than systemically.
Claim 16
Dependent Claim
11 words
The method of claim 11, wherein the thrombus-dissolving medication is urokinase.
Claim 17
Dependent Claim
37 words
The method of claim 14, including delivering said thrombus-dissolving medication in a dosage of from about 6,000 to about 10,000 units, whereby to restrict action thereof to locally in the vicinity of the thrombus rather than systemically.
Claim 18
Dependent Claim
11 words
The method of claim 11, wherein the thrombus-dissolving medication is streptokinase.
Claim 19
Dependent Claim
37 words
The method of claim 16, including delivering said thrombus-dissolving medication in a dosage of from about 5,000 to about 10,000 units, whereby to restrict action thereof to locally in the vicinity of the thrombus rather than systemically.
Claim 20
Dependent Claim
15 words
The method of claim 11, further including removing the fragmented thrombus portion from the vessel.
Claim 21
Dependent Claim
31 words
The method of claim 18, including introducing said laser energy and delivering said thrombus-dissolving medication by means of a single catheter threaded into the patient's vascular system and used for both.
Claim 22
Dependent Claim
18 words
The method of claim 19, including removing said fragmented thrombus portion from the vessel through said single catheter.
Claim 23
Dependent Claim
38 words
The method of claim 11, including generating said shock wave and delivering said thrombus-dissolving medication in successive time intervals of about two minutes each without substantial interruption, and repeating said generating and said delivering successively several times over.
Claim 24
Dependent Claim
48 words
The method of claim 21, including introducing said laser energy and delivering said thrombus-dissolving medication successively through a single catheter introduced into the patient's blood vessel at a point sufficiently close to a site of the thrombus to achieve said fragmenting of the thrombus by synergistic action thereof.
Claim 25
Independent Claim
154 words
A method for removing deposits of thrombus or plaque from the wall of a blood vessel of a patient by synergistic action of two individual procedures, which comprises the steps of introducing a catheter into a blood vessel from which such deposit is to be removed; as a first procedure, delivering laser energy of predetermined wavelength range through an optical fiber in said catheter for preferred absorption by red blood cells in said blood vessel to generate a plasma-based ultrasonic shock wave in the vessel for application to said deposit to create openings therein; as a second procedure, delivering a deposit-dissolving medication into the blood stream in the vicinity of said deposit through a channel in said catheter promptly after completion of the first procedure to penetrate into the openings created in said deposit; and repeating said first and second procedures in that sequence at least once to fragment a portion of said deposit.
Claim 26
Independent Claim
154 words
A method for removing deposits of thrombus or plaque from the wall of a blood vessel of a patient by synergistic action of two individual procedures, which comprises the steps of introducing a catheter into a blood vessel from which such deposit is to be removed; as a first procedure, delivering laser energy of predetermined wavelength range through an optical fiber in said catheter for preferred absorption by red blood cells in said blood vessel to generate a plasma-based ultrasonic shock wave in the vessel for application to said deposit to create openings therein; as a second procedure, delivering a deposit-dissolving medication into the blood stream in the vicinity of said deposit through a channel in said catheter promptly after completion of the first procedure to penetrate into the openings created in said deposit; and repeating said first and second procedures in that sequence at least once to fragment a portion of said deposit.
Claim 27
Dependent Claim
22 words
The method of claim 23, further including removing fragments of said deposit from said blood vessel through said channel in said catheter.
Claim 28
Dependent Claim
34 words
The method of claim 23, wherein the step of repeating said first and second procedures is performed without substantial interruption following completion of performance of an initial sequence of said first and second procedures.
Claim 29
Dependent Claim
33 words
The method of claim 25, including performing said first procedure over a time interval of about two minutes, and then performing said second procedure over a time interval of about another two minutes.
Claim 30
Dependent Claim
26 words
The method of claim 26, including repeatedly performing said first and second procedures in said sequence for an overall duration of at least about ten minutes.
Claim 31
Dependent Claim
54 words
The method of claim 27, wherein the deposit-dissolving medication used in said second procedure is selected from among urokinase, streptokinase, and rTPA, in a dosage selected to restrict the action of said medication to substantially only the locality of said plaque deposit to avoid systemic action of said medication throughout the patient's vascular system.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2001-01-19 | 2001-07-21 | 2002-01-20 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2005-01-19 | 2005-07-21 | 2006-01-20 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2009-01-19 | 2009-07-21 | 2010-01-20 | $7700.00 | Window Closed / Lapsed |